Bharat Parenterals Ltd.
•Market Cap₹ 1,049 Cr.
Current Price
High / Low₹ 1,649 / 1,126
Stock P/E108.4
Book Value₹ 589
Price to Book1.76
Dividend Yield0.07 %
ROCE11.0 %
ROE8.8 %
Face Value₹ 10
Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
Confidence
View full sector analysis →50%
PROS
- Company comfortably covers its interest (8.6x coverage)
- Company maintains a comfortable, low leverage position
CONS
- A large part of profit comes from other income (40.1% of PBT)
- Recent results are weak - TTM profit is down 24.7% versus prior year
- Promoter holding has decreased over last 2 years: -6.1pp
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.10x)
- Operating cash flow has been negative in recent years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | 1930.45 | 38.29 | 463179.62 | 0.83 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| DIVISLAB | 9165.00 | 83.18 | 243301.95 | 0.33 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| TORNTPHARM | 4958.95 | 86.48 | 188622.52 | 0.77 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| ZYDUSLIFE | 1164.05 | 25.73 | 116114.43 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| CIPLA | 1418.00 | 33.99 | 114554.33 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| LAURUSLABS | 1860.00 | 91.92 | 100498.07 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| LUPIN | 2150.00 | 17.78 | 98312.16 | 0.84 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| DRREDDY | 1171.00 | 30.33 | 97741.02 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| MANKIND | 2360.00 | 47.72 | 97478.64 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| AUROPHARMA | 1683.00 | 26.08 | 96836.10 | 0.24 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| GLENMARK | 2464.20 | 38.68 | 69545.80 | 0.10 | 482.83 | 927.88 | 4018.48 | 31.35 | 20.35 | 20.03 |
| BPLPHARMA | 1522.45 | 108.43 | 1049.27 | 0.07 | -3.56 | -309.54 | 93.74 | -19.19 | -4.85 | 9.11 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70 | 60 | 59 | 66 | 92 | 64 | 67 | 80 | 94 | 42 | 41 | 57 | 56 | |
| 58 | 53 | 52 | 62 | 77 | 59 | 59 | 76 | 79 | 39 | 38 | 56 | 52 | |
| Operating Profit | 11 | 6 | 7 | 4 | 15 | 6 | 8 | 5 | 15 | 2 | 3 | 0 | 7 |
| OPM % | 16.44% | 10.75% | 11.53% | 5.70% | 16.27% | 8.78% | 12.40% | 5.73% | 16.17% | 5.61% | 8.38% | 0.07% | 12.30% |
| Other Income | 3 | 3 | 2 | 3 | 4 | 5 | 4 | 2 | 2 | 4 | 2 | 4 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 12 | 8 | 7 | 4 | 16 | 8 | 9 | 4 | 13 | 3 | 3 | 2 | 5 | |
| Tax % | 25.67% | 27.55% | 26.52% | 28.27% | 25.05% | 28.05% | 26.72% | 35.67% | 25.37% | 20.18% | 38.06% | 28.65% | 25.82% |
| Net Profit | 9 | 6 | 5 | 3 | 12 | 5 | 6 | 2 | 10 | 3 | 2 | 1 | 4 |
| 15 | 10 | 9 | 5 | 20 | 8 | 8 | 3 | 15 | 4 | 3 | 2 | 1 | |
| Equity Capital | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 124 | 111 | 136 | 220 | 226 | 204 | 212 | 218 | 258 | 304 | 195 | |
| 114 | 104 | 123 | 190 | 197 | 179 | 184 | 196 | 225 | 271 | 185 | |
| Operating Profit | 15 | 15 | 20 | 43 | 42 | 34 | 36 | 41 | 41 | 48 | — |
| OPM % | 12 | 13 | 15 | 20 | 18 | 17 | 17 | 19 | 16 | 16 | — |
| Other Income | 5 | 8 | 7 | 13 | 12 | 9 | 8 | 19 | 8 | 15 | 12 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 5 | 3 |
| Depreciation | 4 | 6 | 6 | 6 | 6 | 6 | 7 | 6 | 6 | 7 | 9 |
| 9 | 8 | 14 | 36 | 35 | 27 | 28 | 32 | 31 | 36 | 13 | |
| Tax % | 31 | 7 | 27 | 37 | 25 | 25 | 25 | 24 | 27 | 27 | 28 |
| Net Profit | 6 | 7 | 10 | 23 | 26 | 20 | 21 | 24 | 23 | 26 | 10 |
| EPS | 0 | 0 | 0 | 0 | 46 | 35 | 37 | 42 | 39 | 38 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 3 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 11 | 13 | 18 | 39 | 46 | 35 | 37 | 42 | 39 | 38 | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- 10%
- 5 Years:
- 6%
- 3 Years:
- 13%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 14%
- 5 Years:
- 0%
- 3 Years:
- 7%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- 15%
- 5 Years:
- 13%
- 3 Years:
- 11%
- Last Year:
- 9%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 |
| 51 | 58 | 69 | 91 | 117 | 138 | 160 | 185 | 208 | 380 | |
| 13 | 0 | 5 | 2 | 0 | 1 | 3 | 36 | 76 | 60 | |
| Trade Payables | 39 | 36 | 26 | 32 | 43 | 26 | 23 | 48 | 52 | 63 |
| 12 | 10 | 25 | 31 | 26 | 25 | 27 | 34 | 45 | 49 | |
| Total Liabilities | 120 | 110 | 131 | 161 | 192 | 196 | 218 | 308 | 387 | 558 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 35 | 31 | 34 | 34 | 32 | 43 | 40 | 35 | 38 | 45 | |
| Capital Work in Progress | 0 | 0 | 0 | 1 | 12 | 0 | 1 | 0 | 0 | 5 |
| 0 | 1 | 1 | 3 | 2 | 42 | 16 | 38 | 49 | 168 | |
| 14 | 15 | 14 | 21 | 28 | 22 | 21 | 38 | 54 | 47 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 140 | 165 | |
| Cash & Bank | 13 | 2 | 4 | 12 | 10 | 2 | 5 | 7 | 5 | 28 |
| 58 | 62 | 78 | 90 | 109 | 86 | 136 | 189 | 101 | 101 | |
| Total Assets | 120 | 110 | 131 | 161 | 192 | 196 | 218 | 308 | 387 | 558 |
| Total Debt | 19 | 6 | 9 | 5 | 1 | 12 | 15 | 46 | 83 | 65 |
| Net Working Capital | 15 | 21 | 35 | 60 | 70 | 106 | 103 | 66 | 53 | 111 |
| Contingent Liabilities | 14 | 18 | 21 | 22 | 26 | 31 | 23 | 27 | 22 | 51 |
| Book Value per Share | 98.95 | 111.99 | 129.71 | 168.95 | 214.92 | 250.47 | 287.72 | 329.94 | 367.05 | 561.27 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | -2 | 6 | 20 | 14 | 22 | -22 | -12 | -0 | 19 | |
| Cash from Investing | 0 | -2 | -8 | -9 | -13 | -41 | 22 | -14 | -38 | -90 |
| Cash from Financing | 0 | -8 | 4 | -4 | -3 | 11 | 2 | 29 | 34 | 69 |
| 0 | -11 | 2 | 7 | -1 | -8 | 2 | 3 | -5 | -1 | |
| Free Cash Flow | -10 | -2 | -2 | 13 | -0 | 17 | -25 | -12 | -8 | 11 |
| OCF / Net Profit | 0.00 | -0.25 | 0.62 | 0.90 | 0.55 | 1.08 | -1.04 | -0.48 | -0.01 | 0.73 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -0 | 26 | 3 | -7 | -28 | -17 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | ||||||||||
| EPS (₹) | 11.26 | 12.88 | 17.63 | 39.40 | 45.90 | 35.27 | 36.89 | 42.14 | 38.82 | 38.38 |
| Book Value (₹) | 98.95 | 111.99 | 129.71 | 168.95 | 214.92 | 250.47 | 287.72 | 329.94 | 367.05 | 561.27 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.75 | 1.00 | 1.00 |
| Cash EPS (₹) | 18.60 | 22.99 | 27.35 | 50.09 | 56.17 | 45.80 | 48.43 | 52.27 | 49.82 | 48.62 |
| PROFITABILITY | ||||||||||
| Operating Margin % | 11.47% | 12.37% | 14.67% | 19.53% | 18.42% | 14.29% | 15.08% | 16.06% | 12.72% | 11.02% |
| Net Margin % | 4.92% | 6.23% | 7.30% | 10.28% | 11.62% | 8.54% | 8.84% | 9.63% | 8.73% | 8.67% |
| ROE % | 12.10% | 12.21% | 14.59% | 26.38% | 23.92% | 15.16% | 13.76% | 13.65% | 11.18% | 8.81% |
| ROCE % | 15.21% | 12.09% | 19.15% | 39.83% | 31.68% | 19.80% | 17.59% | 16.62% | 12.97% | 10.99% |
| 5.46% | 6.41% | 8.37% | 15.44% | 14.88% | 10.40% | 10.29% | 9.25% | 6.50% | 5.60% | |
| EFFICIENCY | ||||||||||
| Debtor Days | 142 | 136 | 136 | 103 | 119 | 115 | 107 | 134 | 178 | 182 |
| Inventory Days | 38 | 45 | 39 | 30 | 39 | 39 | 33 | 42 | 65 | 61 |
| Payable Days | 183 | 173 | 130 | 75 | 92 | 94 | 65 | 94 | 115 | 111 |
| -3 | 7 | 44 | 58 | 66 | 60 | 74 | 83 | 127 | 132 | |
| FINANCIAL HEALTH | ||||||||||
| Debt to Equity (x) | 0.34x | 0.10x | 0.12x | 0.05x | 0.01x | 0.09x | 0.09x | 0.24x | 0.39x | 0.17x |
| Interest Coverage (x) | 7.29x | 9.80x | 15.67x | 42.43x | 41.48x | 36.56x | 22.73x | 13.54x | 9.11x | 8.59x |
| 1.27x | 1.50x | 1.62x | 2.00x | 2.07x | 3.58x | 3.57x | 1.61x | 1.32x | 1.68x | |
| GROWTH | ||||||||||
| Revenue Growth % | 4.52% | -10.38% | 22.57% | 61.14% | 3.02% | -10.01% | 4.10% | 2.81% | 18.35% | 17.89% |
| Operating Profit Growth % | -0.15% | -2.49% | 38.37% | 111.53% | -2.83% | -18.92% | 7.47% | 11.69% | 1.02% | 17.46% |
| Net Profit Growth % | -13.25% | 14.36% | 36.86% | 123.51% | 16.51% | -23.16% | 5.41% | 14.24% | -7.16% | 17.08% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -7.88% | -1.13% | |
| VALUATION | ||||||||||
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 28.91x | 25.73x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 3.06x | 1.76x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.09% | 0.10% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 17.83x | 14.90x |
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for BPLPHARMA
Loading news…
🤖
AI Stock Analyst
Bharat Parenterals Ltd.
🔒
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account